Biological variation in inflammatory and hemostatic markers

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 8, 2009, Pages 1247-1255

  Rudez G ^a   Meijer, P ^a   Spronk, H M H ^c   Leebeek, F W G ^a   ten Cate, H ^c   Kluft, C ^b   de Maat, Monick P M ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ECAT Foundation   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Bological variation; Coagulation; Inflammation; Platelets; Seasonal variation

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; THROMBIN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BIOLOGICAL MONITORING; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTHROMBIN TIME; REFERENCE VALUE; REPEAT PROCEDURE; SEASONAL VARIATION; THROMBOCYTE AGGREGATION;

ADULT; AGED; BIAS (EPIDEMIOLOGY); BIOLOGICAL MARKERS; BLOOD COAGULATION TESTS; C-REACTIVE PROTEIN; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PLATELET AGGREGATION; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SEASONS; YOUNG ADULT;

EID: 67949091192     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03488.x     Document Type: Article

References (33)

1. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-5.
2. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-97.
3. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-34.
4. Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, Greenberg H, Weiss HJ, Zareba W, Brown MW, Liang CS, Lichstein E, Little WC, Gillespie JA, van Voorhees L, Krone RJ, Bodenheimer MM, Hochman J, Dwyer EM Jr, Arora R, Marcus FI, et al. Thrombogenic factors and recurrent coronary events. Circulation 1999; 99: 2517-22.
5. Freedman DS, Byers T, Barboriak JJ, Flanders WD, Duncan A, Yip R, Meilahn EN. The relation of prothrombin times to coronary heart disease risk factors among men aged 31-45years. Am J Epidemiol 1992; 136: 513-24.
6. Verschuur M, van der Beek MT, Tak HS, Visser LG, de Maat MP. Interindividual variation in the response by fibrinogen, C-reactive protein and interleukin-6 to yellow fever vaccination. Blood Coagul Fibrinolysis 2004; 15: 399-404.
7. Reynolds TM, Twomey P, Wierzbicki AS. Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetes. J Cardiovasc Risk 2002; 9: 183-90.
8. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, Minchinela J, Perich C, Simon M. http://www.westgard.com/ biodatabase1.htm 2008.
9. Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade TW. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: Winter infections and death from cardiovascular disease. Lancet 1994; 343: 435-9.
10. van Gestel MA, Heemskerk JW, Slaaf DW, Heijnen VV, Reneman RS, Oude Egbrink MG. In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability. Arterioscler Thromb Vasc Biol 2003; 23: 518-23.
11. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
12. Dielis AW, Castoldi E, Spronk HM, van Oerle R, Hamulyak K, ten Cate H, Rosing J. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2008; 6: 125-31.
13. Euser AM, Dekker FW, le Cessie S. A practical approach to Bland-Altman plots and variation coefficients for log transformed variables. J Clin Epidemiol 2008; 61: 978-82.
14. Harris EK. Statistical principles underlying analytic goal-setting in clinical chemistry. Am J Clin Pathol 1979; 72: 374-82.
15. Cotlove E, Harris EK, Williams GZ. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 3. Physiological and medical implications. Clin Chem 1970; 16: 1028-32.
16. Harris EK. Proposed goals for analytical precision and accuracy in single-point diagnostic testing. Theoretical basis and comparison with data from College of American Pathologists proficiency surveys. Arch Pathol Lab Med 1988; 112: 416-20.
17. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27: 409-37.
18. Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997; 34: 8-12.
19. Fraser CG ed. Biological Variation: From Principles to Practice. Washington, DC: AACC Press, 2001.
20. van der Bom JG, de Maat MP, Bots ML, Hofman A, Kluft C, Grobbee DE. Seasonal variation in fibrinogen in the Rotterdam study. Thromb Haemost 1997; 78: 1059-62.
21. Rao CR. Linear Statistical Inference and Its Applications, 2nd edn. New York: Wiley, 1973. 418-9.
22. de Maat MP, de Bart AC, Hennis BC, Meijer P, Havelaar AC, Mulder PG, Kluft C. Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler Thromb Vasc Biol 1996; 16: 1156-62.
23. Marckmann P, Sandstrom B, Jespersen J. The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis 1992; 96: 235-44.
24. Kluft C, de Maat MP. Determination of the habitual low blood level of C-reactive protein in individuals. Ital Heart J 2001; 2: 172-80.
25. Linnemann B, Schwonberg J, Mani H, Prochnow S, Lindhoff-Last E. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: An adjustment for platelet count is not necessary. J Thromb Haemost 2008; 6: 677-83.
26. Devreese K, Wijns W, Combes I, Van kerckhoven S, Hoylaerts MF. Thrombin generation in plasma of healthy adults and children: Chromogenic versus fluorogenic thrombogram analysis. Thromb Haemost 2007; 98: 600-13.
27. Riese H, Vrijkotte TG, Meijer P, Kluft C, de Geus EJ. Diagnostic strategies for C-reactive protein. BMC Cardiovasc Disord 2002; 2: 9.
28. Yee DL, Sun CW, Bergeron AL, Dong JF, Bray PF. Aggregometry detects platelet hyperreactivity in healthy individuals. Blood 2005; 106: 2723-9.
29. Feng D, Lindpaintner K, Larson MG, Rao VS, O'Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Silbershatz H, D'Agostino RB, Muller JE, Myers RH, Levy D, Tofler GH. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The framingham offspring study. Arterioscler Thromb Vasc Biol 1999; 19: 1142-7.
30. Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny JL, Aiach M, Gaussem P. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003; 108: 989-95.
31. Crawford VL, Sweeney O, Coyle PV, Halliday IM, Stout RW. The relationship between elevated fibrinogen and markers of infection: A comparison of seasonal cycles. QJM 2000; 93: 745-50.
32. Kanikowska D, Grzymislawski M, Wiktorowicz K. Seasonal rhythms of 'acute phase proteins' in humans. Chronobiol Int 2005; 22: 591-6.
33. Stout RW, Crawford VL, McDermott MJ, Rocks MJ, Morris TC. Seasonal changes in haemostatic factors in young and elderly subjects. Age Ageing 1996; 25: 256-8.